Amlodipine

is prescribed to treat:

• High blood pressure (hypertension) • Chronic stable angina (chest pain) • Vasospastic angina (Prinzmetal's angina) • Coronary artery disease • Often combined with other blood pressure medications

It helps prevent strokes, heart attacks, and kidney problems.

Amlodipine (Norvasc) is a dihydropyridine calcium channel blocker used for high blood pressure and for angina. Within its class it is defined by an unusually long half-life of 30 to 50 hours, which gives smooth 24-hour blood pressure control from a single daily dose and makes it forgiving of a missed dose — a meaningful advantage in a condition treated for decades.

Mechanism of Action

Amlodipine blocks L-type calcium channels in vascular smooth muscle, reducing calcium entry and therefore reducing the muscle tone of arterial walls. The result is arterial vasodilation and a fall in systemic vascular resistance, which lowers blood pressure. In angina, the same vasodilation reduces the afterload the heart works against and improves coronary blood flow.

The important distinction within the calcium channel blocker class is selectivity. Dihydropyridines such as amlodipine act almost entirely on vascular smooth muscle and have minimal effect on cardiac conduction. Non-dihydropyridines — diltiazem and verapamil — also slow the sinoatrial and atrioventricular nodes, which makes them useful for rate control in atrial fibrillation but hazardous in combination with beta blockers or in reduced ejection fraction.

That selectivity is why amlodipine does not slow heart rate. It also explains its characteristic side effect. Dihydropyridines dilate arterioles more than venules, raising capillary hydrostatic pressure and pushing fluid into the interstitium. The resulting ankle edema is dose-dependent, affects women more than men, and is not a sign of fluid overload or heart failure — diuretics do not relieve it well. Adding an ACE inhibitor or ARB, which dilates the venous side, does reduce it, which is one reason those combinations are common.

Clinical Use

Amlodipine is a first-line antihypertensive and is often the preferred initial choice in older adults and in Black patients, groups in whom calcium channel blockers and thiazide diuretics generally outperform ACE inhibitors as monotherapy. It combines particularly well with lisinopril or an ARB such as losartan, and fixed-dose combinations of exactly these pairings are widely used because they improve adherence and reduce edema at the same time.

In stable angina it reduces the frequency of attacks and improves exercise tolerance. It is safe in coronary artery disease and, unlike the non-dihydropyridines, can be used in patients with reduced ejection fraction when another indication requires it, since it is neutral rather than harmful in heart failure.

Amlodipine has no effect on potassium, glucose, or lipids, which makes it a straightforward choice in patients with chronic kidney disease, diabetes, or gout, where other classes create complications. The American Heart Association covers how the antihypertensive classes compare, and the blood pressure numbers article explains the targets. Our cardiovascular team manages combination regimens where a single agent is not enough.

Monitoring and Follow-Up

Monitoring is mainly clinical. Blood pressure is reassessed two to four weeks after starting or changing the dose, and because amlodipine takes seven to ten days to reach steady state, judging its effect earlier than that underestimates it. Home readings are far more informative than isolated office measurements; the home monitoring guide covers correct technique.

Amlodipine requires no routine laboratory monitoring — it does not disturb electrolytes, kidney function, or glucose — which is one of its practical advantages. Ankle edema should be assessed at each visit, since it is the most common reason for discontinuation. If it appears, lowering the dose, adding an ACE inhibitor or ARB, or elevating the legs helps; switching class is a last resort.

Amlodipine is metabolised by CYP3A4. Strong inhibitors raise its levels and can cause hypotension, and simvastatin dosing is capped when combined with amlodipine because the interaction increases myopathy risk. Grapefruit juice has a modest effect. Report any new medication so interactions can be checked.

Amlodipine is often combined rather than escalated. Most patients with stage 2 hypertension need more than one agent, and pairing two drugs at moderate doses controls blood pressure better and with fewer side effects than pushing a single drug to its maximum — dose-dependent edema being the specific reason this holds for amlodipine. Single-pill combinations reduce pill burden and measurably improve adherence. The MedlinePlus amlodipine entry covers the prescribing detail.

Special Populations

In older adults amlodipine is well tolerated and effective, with the caveat that edema and orthostatic symptoms are more common; starting at the lower dose is prudent. Hepatic impairment slows clearance and calls for a reduced starting dose, whereas kidney impairment does not require adjustment, since amlodipine is not renally cleared.

In pregnancy, amlodipine is not a first-line agent — labetalol, nifedipine, and methyldopa have far more accumulated safety data — but it is used when other options fail. Anyone with severe aortic stenosis should use vasodilators cautiously, since reducing afterload in a fixed-obstruction lesion can drop coronary perfusion.

Blood pressure targets have tightened, and the practical consequence is that more patients need more than one drug. Current guidance generally treats to below 130/80 in adults with elevated cardiovascular risk, a target most people cannot reach on a single agent. Reaching it matters: the reduction in stroke and heart failure risk with better control is among the largest and best-established effects in preventive medicine. Amlodipine's tolerability and once-daily dosing make it a durable component of the two- or three-drug regimens that most patients ultimately need, and its lack of metabolic or electrolyte effects means it adds little monitoring burden when it is layered onto other agents.

When to Contact Your Doctor

Report significant or worsening ankle and leg swelling, which is common but manageable and should not simply be endured. Lightheadedness, fainting, or falls suggest the dose is too high. Worsening or more frequent chest pain warrants prompt evaluation rather than dose adjustment at home. Flushing, headache, and palpitations are usually early and self-limiting, but persistent symptoms should be reported. Do not stop amlodipine abruptly without discussing it, particularly if you are being treated for angina.

To review your blood pressure control or discuss side effects that are making treatment hard to sustain, contact us or schedule a visit.